WEKO3
アイテム
Important Roles of Nuclear Cardiology in Cardiac Sarcoidosis
https://repo.qst.go.jp/records/65775
https://repo.qst.go.jp/records/65775e7050587-fdf7-4243-b243-fc326ffbce38
| Item type | 会議発表用資料 / Presentation(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2015-09-29 | |||||
| タイトル | ||||||
| タイトル | Important Roles of Nuclear Cardiology in Cardiac Sarcoidosis | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
| 資源タイプ | conference object | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Yoshinaga, Keiichiro
× Yoshinaga, Keiichiro× 吉永 恵一郎 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Sarcoidosis Immune Granulomas formation in various organ Unknown cause, genetic susceptibility and environmental facors Epidemiology：4.7-64/10 million,Scandinavian 50-60/10 million, Japan 1-2/10 million Peak onset：age 20-39 Outcome：death rate <5%（Pulmonary fibrosis・cardiac・neurologic involvement） Summary Patients with pulmonary sarcoidosis: 9.3% had cardiac involvement, require CS detection in this population RV evaluation: specific for CS FDG PET: Need to establish standard (JSNC guidelines) Useful for evaluate steroid treatment effects Need further prospective studies |
|||||
| 会議概要（会議名, 開催地, 会期, 主催者等） | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | the 20th Annual Scientific Session of the American Society of Nuclear Cardiology | |||||
| 発表年月日 | ||||||
| 日付 | 2015-09-18 | |||||
| 日付タイプ | Issued | |||||
